Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid Alcoholism

NCT00338598 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Alcoholism
Schizophrenia

Interventions

DRUG: Glycine
DRUG: placebo

Sponsor

Yale University

Collaborators

[object Object]